Table 1:

MR imaging and histopathologic findings

NLesions, nBiopsy, nSusECEHistopathology
FrequencyConglomeratesTumor GradeDiagnosis
111313HighGlioblastoma IV
211313HighEpendymoma II
222313HighEpendymoma II
311313HighGlioblastoma IV
321313HighGlioblastoma IV
331313HighGlioblastoma IV
411211HighOligodendroglioma III
511100LowAstrocytoma II
611100IntermediateAstrocytoma II-III
711210HighOligoastrocytoma III
811313HighGlioblastoma IV
911313HighGlioblastoma IV
1011313HighGlioblastoma IV
1111101HighGlioblastoma IV
1211100LowOligoastrocytoma II
1311313HighGlioblastoma IV
1411312HighGlioblastoma IV
1511313HighGlioblastoma IV
1512313HighGlioblastoma IV
1513313HighGlioblastoma IV
1514313HighGlioblastoma IV
1611100HighAstrocytoma III
1711213HighGlioblastoma IV
1722213HighGlioblastoma IV
1811313HighGlioblastoma IV
  • Note:—SusE indicates susceptibility effects. Frequency of SusE: low = 1; medium = 2; high = 3. Formations of conglomerates of intralesional SusE: no = 0; yes = 1. Contrast enhancement: no = 0; minimal = 1; moderate = 2, marked = 3.